Table 1.
Description of the patient base
| Group | n | m/f | Agea | Educationa | MMSE | WST‐IQ | BDI‐II |
|---|---|---|---|---|---|---|---|
| Control | 25 | 8/17 | 64.44 (±5.48) | 11.64 (±3.64) | 29.24 (±.78) | 110.33 (±11.31) | 9.12 (±6.82) |
| MCI | 43 | 24/19 | 65.17 (±6.84) | 11.67 (±4.09) | 28.30 (±1.28) | 108.40 (±11.99) | 10.19 (±6.16) |
| PD‐BMT | 28 | 15/13 | 63.10 (±7.43) | 10.57 (±2.64) | 28.43 (±1.20) | 103.93 (±9.49) | 9.21 (±5.69) |
| PD‐DBS | 22 | 10/12 | 59.69 (±10.28) | 10.77 (±3.69) | 28.36 (±1.50) | 107.62 (±13.59) | 9.77 (±6.91) |
| Total | 118 | 57/61 | 63.50 (±7.66) | 11.24 (±3.61) | 28.54 (±1.26) | 107.58 (±11.68) | 9.65 (±6.28) |
| Significance | .148 | .459 | .001 | .153 | .889 |
Abbreviations: BDI‐II, Beck Depression Inventory; m, male; f, female; MCI, mild cognitive impairment; MMSE, Mini‐Mental State Examination; PD‐BMT, best medically treated Parkinson disease group; PD‐DBS, Parkinson disease patients with deep brain stimulation; WST‐IQ, vocabulary test.
a
In years.